Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Gynecologic Oncology | Sep 19, 2019 Pharmacology/Therapy

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

BMC Cancer | Sep 19, 2019 Pharmacology/Therapy

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells

BMC Cancer | Sep 19, 2019 Pharmacology/Therapy

Predictive and prognostic value of hepatic steatosis in conversion therapy for colorectal liver-limited metastases: A propensity score matching analysis

Cancer Management and Research | Sep 19, 2019 Pharmacology/Therapy

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: A randomised, open-label, phase 1–2 trial

The Lancet Oncology | Sep 18, 2019 Pharmacology/Therapy

Treatment-free survival: A novel outcome measure of the effects of immune checkpoint inhibition—A pooled analysis of patients with advanced melanoma

Journal of Clinical Oncology | Sep 18, 2019 Pharmacology/Therapy

Positron emission tomography–guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase 3 HD16 Trial by the German Hodgkin Study Group

Journal of Clinical Oncology | Sep 18, 2019 Pharmacology/Therapy

Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes

Gynecologic Oncology | Sep 18, 2019 Pharmacology/Therapy

Long-term disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis

The Journal of Thoracic and Cardiovascular Surgery | Sep 18, 2019 Pharmacology/Therapy

Open-label phase 2 evaluation of imatinib in primary inoperable or incompletely resected and recurrent glioblastoma

Oncology | Sep 18, 2019 Pharmacology/Therapy

« Prev 1 … 145 146 147 148 149 … 375 Next »

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells

Predictive and prognostic value of hepatic steatosis in conversion therapy for colorectal liver-limited metastases: A propensity score matching analysis

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: A randomised, open-label, phase 1–2 trial

Treatment-free survival: A novel outcome measure of the effects of immune checkpoint inhibition—A pooled analysis of patients with advanced melanoma

Positron emission tomography–guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase 3 HD16 Trial by the German Hodgkin Study Group

Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes

Long-term disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis

Open-label phase 2 evaluation of imatinib in primary inoperable or incompletely resected and recurrent glioblastoma

Article: A Review on Fluoride Effects on Thyroid Function

Pre-Vodcast Quiz: Test You Knowledge on Key Updates in Cardiogenic Shock Management

Article on Genetic Clues in Parkinsonism: When Should You Suspect an Atypical Hereditary Syndrome?

Article on The Global Threat of Antibiotic Resistance

Speaking more than one language can add layers to stroke recovery

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells

Predictive and prognostic value of hepatic steatosis in conversion therapy for colorectal liver-limited metastases: A propensity score matching analysis

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: A randomised, open-label, phase 1–2 trial

Treatment-free survival: A novel outcome measure of the effects of immune checkpoint inhibition—A pooled analysis of patients with advanced melanoma

Positron emission tomography–guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase 3 HD16 Trial by the German Hodgkin Study Group

Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes

Long-term disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis

Open-label phase 2 evaluation of imatinib in primary inoperable or incompletely resected and recurrent glioblastoma

Article: A Review on Fluoride Effects on Thyroid Function

Pre-Vodcast Quiz: Test You Knowledge on Key Updates in Cardiogenic Shock Management

Article on Genetic Clues in Parkinsonism: When Should You Suspect an Atypical Hereditary Syndrome?

Article on The Global Threat of Antibiotic Resistance

Speaking more than one language can add layers to stroke recovery

Select Specialty

Select Topic